SE421126B - Analogiforfarande for framstellning av optiskt aktiva 1,4-bensodiazepinderivat - Google Patents

Analogiforfarande for framstellning av optiskt aktiva 1,4-bensodiazepinderivat

Info

Publication number
SE421126B
SE421126B SE7507186A SE7507186A SE421126B SE 421126 B SE421126 B SE 421126B SE 7507186 A SE7507186 A SE 7507186A SE 7507186 A SE7507186 A SE 7507186A SE 421126 B SE421126 B SE 421126B
Authority
SE
Sweden
Prior art keywords
preparation
optically active
benzodiazepine derivatives
analogy procedure
analogy
Prior art date
Application number
SE7507186A
Other languages
English (en)
Other versions
SE7507186L (sv
Inventor
A Szente
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7507186L publication Critical patent/SE7507186L/sv
Publication of SE421126B publication Critical patent/SE421126B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7507186A 1974-06-28 1975-06-23 Analogiforfarande for framstellning av optiskt aktiva 1,4-bensodiazepinderivat SE421126B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH892674A CH602672A5 (sv) 1974-06-28 1974-06-28

Publications (2)

Publication Number Publication Date
SE7507186L SE7507186L (sv) 1975-12-29
SE421126B true SE421126B (sv) 1981-11-30

Family

ID=4346371

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7507186A SE421126B (sv) 1974-06-28 1975-06-23 Analogiforfarande for framstellning av optiskt aktiva 1,4-bensodiazepinderivat

Country Status (18)

Country Link
US (1) US4046890A (sv)
JP (1) JPS6050786B2 (sv)
AT (1) AT347468B (sv)
BE (1) BE830722A (sv)
CA (1) CA1048495A (sv)
CH (1) CH602672A5 (sv)
DE (1) DE2526869A1 (sv)
DK (1) DK293375A (sv)
FR (1) FR2276055A1 (sv)
GB (1) GB1444529A (sv)
IE (1) IE41481B1 (sv)
IL (1) IL47263A (sv)
KE (1) KE3004A (sv)
LU (1) LU72837A1 (sv)
NL (1) NL7507682A (sv)
PH (1) PH12433A (sv)
SE (1) SE421126B (sv)
ZA (1) ZA752965B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2834637A1 (fr) * 2002-01-15 2003-07-18 Centre Nat Rech Scient Utilisation d'une nouvelle classe de medicaments pour le traitement de maladies parasitaires
WO2006060736A2 (en) * 2004-12-03 2006-06-08 The Children's Hospital Of Philadelphia A composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121076A (en) * 1964-02-11 Benzodiazepinones and processes
US3123529A (en) * 1964-03-03 -parenteral -compoiaxions -containing
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3248223A (en) * 1962-04-11 1966-04-26 Hoffmann La Roche Animal feeds and methods
GB1056289A (en) * 1964-01-14 1967-01-25 Delmar Chem 2-phthalimido acetamido benzophenones and their preparation
FR1462887A (fr) * 1966-01-06 1966-12-16 Hoffmann La Roche Procédé pour la préparation de dérivés de benzodiazépine
US3998811A (en) * 1971-03-17 1976-12-21 Crc Compagnia Di Recerca Chimica S.A. Optically active 1,4-benzodiazepines and process for the preparation thereof
CH554349A (de) * 1971-03-17 1974-09-30 Crc Ricerca Chim Verfahren zur herstellung von optisch aktiven 1,3-dihydro-2h-1,4-benzodiazepin-2-onen.

Also Published As

Publication number Publication date
IL47263A (en) 1979-03-12
NL7507682A (nl) 1975-12-30
IE41481B1 (en) 1980-01-16
CA1048495A (en) 1979-02-13
FR2276055B1 (sv) 1979-08-17
IE41481L (en) 1975-12-28
SE7507186L (sv) 1975-12-29
ZA752965B (en) 1976-04-28
JPS6050786B2 (ja) 1985-11-11
DE2526869A1 (de) 1976-01-15
KE3004A (en) 1979-12-14
FR2276055A1 (fr) 1976-01-23
IL47263A0 (en) 1975-07-28
LU72837A1 (sv) 1977-03-07
AU8110475A (en) 1976-11-18
ATA497575A (de) 1978-05-15
JPS5123282A (sv) 1976-02-24
PH12433A (en) 1979-02-22
CH602672A5 (sv) 1978-07-31
BE830722A (fr) 1975-12-29
GB1444529A (en) 1976-08-04
DK293375A (da) 1975-12-29
US4046890A (en) 1977-09-06
AT347468B (de) 1978-12-27

Similar Documents

Publication Publication Date Title
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NO142304C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO142173C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme, 1,1-diaryl-1-oksadiazolalkylaminderivater
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE426242B (sv) Analogiforfarande for framstellning av 1,4-bensodiazepinderivat
SE428015B (sv) Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
NO142403C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner.
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE421126B (sv) Analogiforfarande for framstellning av optiskt aktiva 1,4-bensodiazepinderivat
NO139684C (no) Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid
NO145074C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzazepinderivater
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7507922L (sv) Forfarande for framstellning av 2(lh)-kinazolinonderivat.
NO143993C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive guanidinderivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7507186-0

Effective date: 19890721

Format of ref document f/p: F